Learn How

The business of life sciences R&D is fundamentally shifting – from a focus on approval to a broader view on widespread adoption by providers and payers, from proving value in controlled, clinical settings to demonstrating it in target populations and real-world conditions.

Automatically ingest data from dozens of health data sources including...

No items found.
Closedloop icon with a line

ClosedLoop generates explainable predictions using

thousands of auto-generated, clinically relevant contributing factors

No items found.

Real World Outcome Analytics

Gain insights into the patients that benefit from your products and learn how to distinguish who achieves significantly better outcomes than others.  

How much does it improve patient outcomes? Does it outperform alternative therapies? Does it achieve these outcomes at an appropriate value? Which patients are most likely to benefit from it?

  • Understand the health economics and data-driven outcomes for important therapeutic areas
  • Refine key subpopulations, segmentation and targeting capabilities 
  • Identify valuable drug & service offering bundles that drive differential outcomes and pricing options
  • Explore value-based pricing mechanisms and metrics
  • Identify important real-world evidence metrics for R&D processes

Precision Cohorts

Winning is in the details. Success begins with a comprehensive understanding and segmentation of patients.  Our comprehensive AI-enriched patient profiles are enriched with more than 2,000 healthcare features and predicted outcomes.  Use these AI-enriched profiles to define and gain insights into precision cohorts. 

  • Find hard-to-identify patients and under-penetrated segments by applying specific inclusion
    and exclusion criteria 
  • Map the care pathways, medical and social needs, and health-related behaviors of key populations
  • Pinpoint health economic impacts and intervention opportunities (e.g. patients at-risk for fall-related injuries)
  • Target and rank healthcare providers (HCPs) that treat a disproportionate share of key populations

Health Disparities

Understand patients’ medical and social needs; identify populations with disproportionate unmet needs, specific barriers to care, or at risk of non-adherence; and gain insights into the non-clinical factors that impact the patient journey and access to therapy. 

  • Pinpoint patients who might benefit from medication assistance programs, targeted education, delivery services, adherence reminders, or medication management 
  • Prioritize providers who treat these cohorts with tailored messaging
  • Design high-impact support service bundles
  • Understand any differential outcomes for patients that face high social risks 

Citations & Footnotes

ClosedLoop is an exciting and important partner in our strategy to develop timely predictive insights through operationalized AI solutions that will drive member engagement and better health outcomes.

Pat Wang
President & CEO, Healthfirst

Our partnership with ClosedLoop adds the depth of AI to more accurately identify those patients who are most likely to benefit from our primary care interventions as well to evaluate these interventions and make more relevant and timely modifications to improve their effectiveness.

David Klebonis
Chief Operating Officer, PBACO

We are extremely impressed with the predictive modeling capabilities the ClosedLoop platform has delivered. The ClosedLoop team has exceeded all defined goals and benchmarks set to date and we anticipate a substantial return on our investment as these predictions are operationally deployed.

Cheryl Lulias
President & Executive Director, MHN

We’re able to store and operationalize analytics directly from ClosedLoop. That’s driving real value—it’s accelerated the implementation of key insights into clinical workflows and it allows us to more easily account for all of the different factors that influence intervention decisions.

Christer Johnson
Chief Analytics Officer, Healthfirst

At SWHR, our patient-centered network is committed to innovative care models that are value-based, high-quality, and data-driven. Because of our partnership with ClosedLoop, we’re better able to identify and act on the most impactful opportunities for our physician partners to improve patient results and reduce unnecessary costs.

Dr. Jason Fish
Chief Medical Officer & SVP, Southwestern Health Resources

We compared the ClosedLoop predicted spend to the spend predicted by a leading rules-based risk prediction engine and found that 75% of the time ClosedLoop was closer, and in most cases significantly closer, to the actual spend.

Phillip Bruns
Chief Technology Officer, CareATC

Learn What ClosedLoop Can Do for Your Organization

The industry’s best collection of customizable predictive models for common healthcare use cases.

Talk To An Expert